Home/Filings/4/0001415889-21-004885
4//SEC Filing

Bohen Sean 4

Accession 0001415889-21-004885

CIK 0001750284other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 6:44 PM ET

Size

11.2 KB

Accession

0001415889-21-004885

Insider Transaction Report

Form 4
Period: 2021-10-14
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2021-10-14$4.82/sh+5,000$24,12057,514 total
  • Sale

    Common Stock

    2021-10-14$30.42/sh4,649$141,42352,865 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-10-145,000966,316 total
    Exercise: $4.82Exp: 2030-11-18Common Stock (5,000 underlying)
  • Sale

    Common Stock

    2021-10-14$31.17/sh351$10,94152,514 total
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  • [F2]The weighted average sale price for the transaction reported was $30.42, and the range of prices were between $30.00 and $30.99. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F3]The weighted average sale price for the transaction reported was $31.17, and the range of prices were between $31.00 and $31.28. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F4](A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001831218

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 6:44 PM ET
Size
11.2 KB